rs727503153

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_001393500.2(TOMT):​c.745A>C​(p.Ile249Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000239 in 1,548,406 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

TOMT
NM_001393500.2 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 4.55

Publications

0 publications found
Variant links:
Genes affected
TOMT (HGNC:55527): (transmembrane O-methyltransferase) This gene encodes a catechol-O-methyltransferase that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to a hydroxyl group of catechols and is essential for auditory and vestibular function. Mutations in this gene have been associated with nonsyndromic deafness. Readthrough transcription is observed across this gene and the adjacent leucine-rich repeat containing 51 gene. A third locus (GeneID:220074) is defined to represent the readthrough transcripts. [provided by RefSeq, Feb 2021]
LRTOMT (HGNC:25033): (leucine rich transmembrane and O-methyltransferase domain containing) This locus represents naturally occurring readthrough transcription between the neighboring LRRC51 (leucine-rich repeat containing 51) and TOMT (transmembrane O-methyltransferase) genes on chromosome 11. The readthrough transcript encodes a fusion protein that shares sequence identity with each individual gene product. Multiple reports implicate mutations in this gene in nonsyndromic deafness.[provided by RefSeq, Feb 2021]
ANAPC15 (HGNC:24531): (anaphase promoting complex subunit 15) Involved in regulation of mitotic cell cycle spindle assembly checkpoint. Part of anaphase-promoting complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07813221).
BP6
Variant 11-72108893-A-C is Benign according to our data. Variant chr11-72108893-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 163944.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TOMTNM_001393500.2 linkc.745A>C p.Ile249Leu missense_variant Exon 3 of 3 ENST00000541899.3 NP_001380429.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TOMTENST00000541899.3 linkc.745A>C p.Ile249Leu missense_variant Exon 3 of 3 5 NM_001393500.2 ENSP00000494667.1
LRTOMTENST00000307198.11 linkc.844A>C p.Ile282Leu missense_variant Exon 7 of 7 2 ENSP00000305742.7

Frequencies

GnomAD3 genomes
AF:
0.000119
AC:
18
AN:
151818
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000411
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000132
AC:
2
AN:
151476
AF XY:
0.0000124
show subpopulations
Gnomad AFR exome
AF:
0.000252
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000136
AC:
19
AN:
1396588
Hom.:
0
Cov.:
32
AF XY:
0.0000131
AC XY:
9
AN XY:
688754
show subpopulations
African (AFR)
AF:
0.000380
AC:
12
AN:
31584
American (AMR)
AF:
0.0000561
AC:
2
AN:
35634
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25066
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35726
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79112
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47830
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5676
European-Non Finnish (NFE)
AF:
9.28e-7
AC:
1
AN:
1078050
Other (OTH)
AF:
0.0000691
AC:
4
AN:
57910
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000119
AC:
18
AN:
151818
Hom.:
0
Cov.:
32
AF XY:
0.000108
AC XY:
8
AN XY:
74158
show subpopulations
African (AFR)
AF:
0.000411
AC:
17
AN:
41404
American (AMR)
AF:
0.0000655
AC:
1
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67872
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000987
Hom.:
0
Bravo
AF:
0.000110

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jun 26, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis suggests that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

not specified Benign:1
May 31, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ile282Leu in exon 7 of LRTOMT: This variant is not expected to have clinical sig nificance due to a lack of conservation across species, including mammals. Of no te, shrew, wallaby and opossum have a leucine (Leu) at this position despite hig h nearby amino acid conservation. In addition, computational analyses (PolyPhen2 , SIFT, AlignGVGD) do not suggest a high likelihood of impact to the protein. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
16
DANN
Benign
0.76
DEOGEN2
Benign
0.032
T;T;.
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.30
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.69
T;.;T
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.078
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-0.20
N;N;.
PhyloP100
4.6
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
0.68
N;N;.
REVEL
Benign
0.093
Sift
Benign
1.0
T;T;.
Sift4G
Benign
1.0
T;T;.
Polyphen
0.0010
B;B;.
Vest4
0.15
MutPred
0.62
Gain of catalytic residue at I282 (P = 0.0168);Gain of catalytic residue at I282 (P = 0.0168);.;
MVP
0.47
MPC
0.063
ClinPred
0.050
T
GERP RS
3.1
Varity_R
0.25
gMVP
0.68
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs727503153; hg19: chr11-71819939; API